Emerging treatments in HER2-positive advanced breast cancer: Keep raising the bar.

Auteurs

Agostinetto E, Curigliano G, Piccart M

  • Date de publication

    Mei 2024

  • Type

    Review

  • Tijdschrift

    Cell Rep Med

  • Naam van de onderzoeker

    AGOSTINETTO ELISA

  • Hôpital

    Institut Jules Bordet

  • Dienst

    Academic trials promoting Team, Direction administrative de la recherche, Médecine Oncologique

  • PMID

    38759648

  • DOI

    10.1016/j.xcrm.2024.101575